Status quo of hybrid coronary revascularization for multi-vessel coronary artery disease

Published

Journal Article (Review)

Hybrid coronary revascularization (HCR) combines bypass grafting of the left anterior descending (LAD) coronary artery with percutaneous coronary intervention (PCI) of non-LAD vessels. HCR has been performed as an alternative to CABG or multi-vessel PCI in thousands of patients since the late 1990s. In this review article, we provide an overview on patient selection, procedural sequence and timing, use of surgical techniques and anti-platelet agents. Additionally, patient recovery, satisfaction, costs and clinical outcomes of individual studies after HCR are evaluated. Future directions are also discussed, including the need for adequately powered randomized trials. © 2013 by The Society of Thoracic Surgeons.

Full Text

Duke Authors

Cited Authors

  • Harskamp, RE; Zheng, Z; Alexander, JH; Williams, JB; Xian, Y; Halkos, ME; Brennan, JM; De Winter, RJ; Smith, PK; Lopes, RD

Published Date

  • December 1, 2013

Published In

Volume / Issue

  • 96 / 6

Start / End Page

  • 2268 - 2277

Electronic International Standard Serial Number (EISSN)

  • 1552-6259

International Standard Serial Number (ISSN)

  • 0003-4975

Digital Object Identifier (DOI)

  • 10.1016/j.athoracsur.2013.07.093

Citation Source

  • Scopus